RESMED INC 4

4 · RESMED INC · Filed May 16, 2012

Form 4

Period: 2012-05-14

Director

Transactions

Exercise/Conversion
ResMed Common Stock
2012-05-14$9.80/sh+12,000$117,576→ 314,000 total
Exercise/Conversion
ResMed Common Stock Options
2012-05-14−24,000→ 0 total
Exercise: $23.09From: 2007-11-10Exp: 2013-11-10→ ResMed Common Stock (24,000 underlying)
Sale
ResMed Common Stock
2012-05-14$33.30/sh−12,000$399,619→ 302,000 total
Exercise/Conversion
ResMed Common Stock Options
2012-05-14−24,000→ 12,000 total
Exercise: $9.80From: 2004-07-07Exp: 2013-07-07→ 24,000 (24,000 underlying)
Sale
ResMed Common Stock
2012-05-14$33.26/sh−12,000$399,120→ 302,000 total
Exercise/Conversion
ResMed Common Stock
2012-05-14$23.09/sh+12,000$277,140→ 314,000 total

Holdings

Footnotes (4)

[F1]Represents date options first became exercisable. Options vest 1/12 per month and are fully vested at one year.
[F2]Represents date options first became exercisable. Options vest 1/3 annually on the anniversary of the grant.
[F3]This transaction was executed in multiple trades at prices ranging from $33.26 and 33.31. The price reported above reflects the weighted average sale price. The reporting person will provide full information regarding the number of shares and prices at which the transaction was effected upon request to the SEC staff, the issuer or the security holder of the issuer.
[F4]Previously reported as 40,000 NYSE shares. 1 NYSE share is equal to 10 CDIs.

Documents

1 file